Non-Coding RNAs Regulate Spinal Cord Injury-Related Neuropathic Pain via Neuroinflammation
DOI: https://doi.org/10.2147/JIR.S413264
IF: 4.5
2023-06-13
Journal of Inflammation Research
Abstract:Jing Zhu, 1, &ast Fei Huang, 1, 2, &ast Yonglin Hu, 1, 3, &ast Wei Qiao, 1 Yingchao Guan, 1 Zhi-Jun Zhang, 1, &ast Su Liu, 1 Ying Liu 4 1 Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, JiangSu Province, 226001, People's Republic of China; 2 Department of Rehabilitation Medicine, Nantong Health College of Jiangsu Province, Nantong, JiangSu Province, 226010, People's Republic of China; 3 Affiliated Nantong Rehabilitation Hospital of Nantong University, Nantong, JiangSu Province, 226001, People's Republic of China; 4 Department of Pathology, Affiliated Hospital of Nantong University, Nantong, JiangSu Province, 226001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ying Liu, Department of Pathology, Affiliated Hospital of Nantong University, Nantong, 226001, JiangSu Province, People's Republic of China, Email Su Liu, Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Nantong, JiangSu Province, 226001, People's Republic of China, Email Secondary chronic neuropathic pain (NP) in addition to sensory, motor, or autonomic dysfunction can significantly reduce quality of life after spinal cord injury (SCI). The mechanisms of SCI-related NP have been studied in clinical trials and with the use of experimental models. However, in developing new treatment strategies for SCI patients, NP poses new challenges. The inflammatory response following SCI promotes the development of NP. Previous studies suggest that reducing neuroinflammation following SCI can improve NP-related behaviors. Intensive studies of the roles of non-coding RNAs in SCI have discovered that ncRNAs bind target mRNA, act between activated glia, neuronal cells, or other immunocytes, regulate gene expression, inhibit inflammation, and influence the prognosis of NP. Keywords: non‐coding RNAs, neuroinflammation, neuropathic pain, spinal cord injury Spinal cord injury (SCI) is often accompanied by major impairments in motor, sensory, and autonomic functions. 1 The molecular and biochemical pathways associated with the pathophysiology of SCI include intra-tissue hypoxia, oxidative stress, inflammation, apoptosis, and so on. SCI is classified as primary or secondary. Common symptoms of SCI include neuropathic pain (NP), spasticity, abnormal autonomic reflexes, and impairment of social, recreational, and occupational activities. 2 Primary SCI can trigger secondary SCI, resulting in further chemical and mechanical damage to tissues. A common secondary complication of SCI is NP, which patients usually experience spontaneously, abnormally, or with hypersensitivity to pain. 3 Severe SCI-related NP is associated with decreased quality of life. Conventional treatments have difficulty resolving severe NP, and many clinical needs remain unmet. Despite the many therapeutic strategies proposed and various breakthroughs achieved, cure remains elusive, probably due to the complex healing and protective mechanisms involved. 4–6 Neuroinflammation (NI) is a coordinated response of the immune system against infection following SCI. 7 In the past decade or so, NI following SCI was linked to intractable NP. Anatomical alterations associated with SCI include disruption of the blood-spinal cord barrier. 8,9 During blood-spinal cord barrier disruption, immune cells will enter the spinal cord parenchyma and cause direct inflammation. Neurons, neutrophils, microglia, macrophages, astrocytes, and B and T lymphocytes, as well as cytokines contribute to this mechanistic process. SCI-induced NI produces NP and promotes NP-related behaviors. 10–14 Disruption of the blood-spinal cord barrier and subsequent infiltration of leukocytes induces central NI, as well as activation, migration, and proliferation of microglia and astrocytes, which can promote the production and release of inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, which have been associated with behavioral indicators of SCI-related NP. 8,15–19 A growing body of evidence suggests that NI following SCI can prolong NP. 7 Non-coding RNAs (ncRNAs), which include microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play important roles in regulation of gene expression in central nervous system. In this review, we discuss how ncRNAs expression changes are associated with SCI-related NP. Except for miRNAs, IncRNAs and circRNAs, NP is rarely associated with other types of ncRNAs, and these are not discu -Abstract Truncated-
immunology